News

  1. 12/06/2018 Catalent Celebrates 20 Years at Philadelphia Facility

  2. 12/03/2018 Catalent Invests to Expand Biologics Packaging Capabilities at Bloomington

  3. 12/03/2018 Biohaven Delivers Positive Phase 3 Results with Rimegepant

  4. 11/27/2018 Catalent Expands Clinical Packaging Capabilities in Shanghai, China

  5. 11/26/2018 Biohaven announces FDA acceptance of 505(b)(2) NDA filing for BHV-0223

  6. 11/15/2018 Catalent to Discuss Brexit at Partnerships in Clinical Trials Conference

  7. 11/13/2018 Catalent to Open Second Clinical Supply Facility in China

  8. 11/06/2018 Bioprocessing and Cell Line Development to be Presented at Waterside Conference

  9. 10/30/2018 Catalent to Lead Debate on Developability Classification System at AAPS

  10. 10/17/2018 Patient-Focused Drug Delivery to be Presented by Catalent at PODD

  11. 10/16/2018 Catalent & Verastem Oncology Partner on FDA Approved COPIKTRA

  12. 10/15/2018 Phase-Appropriate Validation of Bioassays to be Presented at WCBBA

  13. 10/11/2018 Catalent Clinical Supply Experts Present at Industry Conferences

  14. 10/04/2018 Catalent Invests $7.3 Million at Aprilia Facility

  15. 09/26/2018 Catalent to Provide Oral Delivery Systems for Parkinson’s Disease Therapies

  16. 09/20/2018 Lipid-Based Drug Delivery Presented by Catalent and BASF

  17. 09/04/2018 Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent

  18. 08/30/2018 Catalent Experts to Discuss Biologics Development and Manufacturing at BPI East

  19. 08/14/2018 Catalent Completes Tender Offer for Juniper Pharmaceuticals, Inc.

  20. 08/09/2018 Catalent Biologics Expert to Discuss Assay Automation at IDDST

  21. 07/17/2018 Catalent Experts at Upcoming Controlled Release Society Conference

  22. 07/12/2018 Catalent Appoints Marlene Leuenberger as General Manager

  23. 07/10/2018 Catalent Biologics Adopts Berkeley Lights’ Beacon® Optofluidic Platform

  24. 07/03/2018 Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

  25. 06/26/2018 Catalent Biologics Appoints New General Manager for Madison, Wisconsin

  26. 06/13/2018 Catalent Appoints Paul Hegwood as New President of Clinical Supply Services

  27. 06/07/2018 Biological Drug Development & Delivery at Catalent Institute / JLABS Symposium

  28. 05/31/2018 Catalent Biologics Supports New Methamphetamine Treatment

  29. 05/17/2018 Catalent Completes $5.5 Million Expansion at Kansas City

  30. 05/14/2018 Catalent Biologics and Valerius Biopharma to Collaborate on Biosimilars

  31. 05/09/2018 Biohaven announces Expanded Access Program for Patients with ALS

  32. 04/24/2018 Catalent Invest $5 million to Create Drug Development Center of Excellence

  33. 04/19/2018 Catalent to Lead Multiple Workshops at Upcoming US GCSG Conference

  34. 04/12/2018 Catalent Completes $5.5 Million Expansion at Philadelphia Facility

  35. 04/11/2018 Catalent to Present at Upcoming INTERPHEX Convention

  36. 03/08/2018 Catalent To Discuss Potential Implications of Brexit on Clinical Supply

  37. 03/01/2018 Catalent Institute to Host Discussion on Patient-Focused Drug Design

  38. 02/28/2018 Catalent Completes $4.6 Million Expansion at Singapore Facility

  39. 02/22/2018 Catalent to Present at Clinical Trial Supply New England

  40. 02/21/2018 Biohaven Announces Exclusive License with Catalent for Zydis® ODT

  41. 02/05/2018 Catalent Recognized with 10 CMO Leadership Awards

  42. 01/29/2018 Catalent Biologics to Present at CASSS WCBP Symposium